Dow Up0.25% Nasdaq Up0.65%

BioMarin Pharmaceutical Inc. (BMRN)

-NasdaqGS
89.09 Up 1.83(2.10%) May 27, 4:00PM EDT
|After Hours : 89.08 Down 0.01 (0.01%) May 27, 7:24PM EDT
Analyst OpinionGet Analyst Opinion for:
Recommendation Summary*
Mean Recommendation (this week):1.8
Mean Recommendation (last week):1.8
Change:0.0

* (Strong Buy) 1.0 - 5.0 (Sell)

Price Target Summary
Mean Target:114.68
Median Target:110.00
High Target:150.00
Low Target:99.00
No. of Brokers:19

Data provided by Thomson/First Call

Upgrades & Downgrades History
DateResearch FirmActionFromTo
Mar 8, 2016Robert W. BairdUpgradeNeutralOutperform
Feb 16, 2016StifelUpgradeHoldBuy
Jan 20, 2016Credit SuisseInitiated Outperform
Nov 18, 2015GoldmanInitiated Buy
Oct 2, 2015Raymond JamesInitiated Outperform
Sep 1, 2015Raymond JamesInitiated Outperform
Jun 19, 2015Robert W. BairdDowngradeOutperformNeutral
Jun 5, 2015BarclaysInitiated Overweight
Jan 10, 2014BarclaysDowngradeOverweightEqual Weight
Sep 18, 2013StifelDowngradeBuyHold

More Upgrades & Downgrades for BMRN

Data provided by Briefing.com - Take a free trial
Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

Recommendation Trends
Current MonthLast MonthTwo Months AgoThree Months Ago
Strong Buy6664
Buy11121111
Hold2224
Underperform0000
Sell0000

Data provided by Thomson/First Call


Currency in USD.